Bitget App
Trade smarter
US-listed company LIXTE Biotechnology launches crypto reserve strategy, plans to allocate 25% of funds to BTC
View original
According to ChainCatcher, Nasdaq-listed company LIXTE Biotechnology has announced that its board of directors has approved a strategic capital allocation plan to acquire cryptocurrencies as part of the company’s funds. The board has also approved allocating 25% of its funds to cryptocurrencies, including Bitcoin and potentially other digital assets as appropriate.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Locked for new tokens.
APR up to 10%. Always on, always get airdrop.
Lock now!
You may also like
Sign Foundation completes first $12 million SIGN buyback
Chaincatcher•2025/08/13 13:12
20,000 Ether Transferred from Abraxas to an Exchange
金色财经•2025/08/13 12:56
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$120,586.44
+1.20%
Ethereum
ETH
$4,726.19
+7.17%
XRP
XRP
$3.32
+4.23%
Tether USDt
USDT
$0.9994
-0.09%
BNB
BNB
$856.61
+5.38%
Solana
SOL
$203.3
+14.26%
USDC
USDC
$0.9996
-0.02%
Dogecoin
DOGE
$0.2475
+9.35%
TRON
TRX
$0.3585
+3.17%
Cardano
ADA
$0.8857
+11.73%
How to sell PI
Bitget lists PI – Buy or sell PI quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now